Andrea Decensi

Genoa, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 116 publications

Low-Dose Tamoxifen in Noninvasive Breast Neoplasia: Long-Term Results From an Individual-Participant Data Pooled Analysis.

Low-Dose Tamoxifen in Noninvasive Breast Neoplasia: Long-Term Results From an Individual-Participant Data Pooled Analysis.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: May 31, 2026

Automatic metabolic breast cancer staging using [¹⁸F]FDG PET/CT: comparison with nuclear medicine physician-based and clinical staging.

Automatic metabolic breast cancer staging using [¹⁸F]FDG PET/CT: comparison with nuclear medicine physician-based and clinical staging.

Journal: European journal of nuclear medicine and molecular imaging

Published: March 11, 2026

Letrozole for hormone receptor-positive low-grade ovarian cancer: Preliminary toxicity results of a phase III trial.

Letrozole for hormone receptor-positive low-grade ovarian cancer: Preliminary toxicity results of a phase III trial.

Journal: Tumori

Published: December 15, 2025

The Long and Winding Road toward Prevention of Estrogen Receptor-Negative and BRCA1-Associated Breast Cancer.

The Long and Winding Road toward Prevention of Estrogen Receptor-Negative and BRCA1-Associated Breast Cancer.

Journal: Cancer prevention research (Philadelphia, Pa.)

Published: November 22, 2025

The role of the molecular tumor board: learnings from the ROME trial.

The role of the molecular tumor board: learnings from the ROME trial.

Journal: NPJ precision oncology

Published: November 18, 2025

European Code Against Cancer, 5th edition - hormone replacement therapy, other common medical therapies and cancer.

European Code Against Cancer, 5th edition - hormone replacement therapy, other common medical therapies and cancer.

Journal: Molecular oncology

Published: August 01, 2025

European Code Against Cancer, 5th edition - organised cancer screening programmes.

European Code Against Cancer, 5th edition - organised cancer screening programmes.

Journal: Molecular oncology

Published: July 24, 2025

Effect of low-dose tamoxifen on benign gynecological and breast conditions in a phase 3 trial in noninvasive breast cancer.

Effect of low-dose tamoxifen on benign gynecological and breast conditions in a phase 3 trial in noninvasive breast cancer.

Journal: Journal of the National Cancer Institute

Published: May 21, 2025

Time-Restricted Eating and Metformin in Invasive Breast Cancer or DCIS: A Randomized, Phase IIb, Presurgical Trial. Preliminary Safety Analysis.

Time-Restricted Eating and Metformin in Invasive Breast Cancer or DCIS: A Randomized, Phase IIb, Presurgical Trial. Preliminary Safety Analysis.

Journal: Cancer prevention research (Philadelphia, Pa.)

Published: April 01, 2025

Colorectal cancer-infiltrating NK cell landscape analysis unravels tissue-resident PD-1+ NK cells in microsatellite instability tumors.

Colorectal cancer-infiltrating NK cell landscape analysis unravels tissue-resident PD-1+ NK cells in microsatellite instability tumors.

Journal: Frontiers in immunology

Published: February 17, 2025

The Impact of Concordance between Liquid and Tissue Biopsy for Actionable Mutations: Insights from the ROME Trial.

The Impact of Concordance between Liquid and Tissue Biopsy for Actionable Mutations: Insights from the ROME Trial.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: February 04, 2025

Genomically matched therapy in advanced solid tumors: the randomized phase 2 ROME trial.

Genomically matched therapy in advanced solid tumors: the randomized phase 2 ROME trial.

Journal: Nature medicine

Published: December 27, 2024

Showing 1-12 of 116

Last Updated: 09/26/2026